Skip to content

VALN

Valneva SE

NASDAQ · Healthcare · Biotechnology · FR

$6.56
−0.15%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 19, 2026
EPS estimate
-$0.17
Revenue estimate
$43.8M

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$0.40
EPS estimate
-$0.28
Revenue actual
$40.3M
Revenue estimate
$48.2M

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
8
EPS in line (12Q)
0
Avg surprise (4Q)
-71.2%
Revenue beats (12Q)
4
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$0.28-$0.40Miss -42.86%$40.3M
May 13, 2026-$0.21-$0.42Miss -100.00%$36.2M
Mar 18, 2026-$0.17-$0.24Miss -38.73%$54.6M
Nov 20, 2025-$0.30-$0.61Miss -103.33%$34.4M
Aug 12, 2025-$0.27-$0.16Beat 40.74%$56.9M
Mar 20, 2025-$0.22-$0.54Miss -145.45%$54.8M
Nov 7, 2024-$0.30-$0.15Beat 50.00%$50.3M
Mar 20, 2024$0.20-$0.50Miss -350.00%$46.1M
Nov 9, 2023-$0.51-$0.54Miss -5.88%$40.2M
Sep 21, 2023-$0.36-$0.26Beat 27.78%$43.9M
May 4, 2023-$0.35-$0.28Beat 20.00%$36.4M
Mar 23, 2023$0.29-$0.65Miss -324.14%$120.0M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026